Additionally, differences in phenotypes between the PTHrP mutant cells are likely not due to paracrine effects of secreted PTHrP since we and others have previously shown that PTHrP does not activate PTH1R or downstream cAMP signaling in breast cancer cells [37, 38]. The gene discussed is PTH1R; the disease is breast carcinoma.